“…In the last two decades, much effort has been devoted to finding non-invasive methods of predicting the presence of EVs and HREVs. Currently, non-invasive predictive parameters are predominantly imaging/ultrasonographic and laboratory parameters, including spleen diameter, spleen/liver stiffness, portal/splenic vein diameter, platelet count, platelet count to spleen diameter ratio, Fibrosis-4 score (FIB-4), aspartate aminotransferase to platelet ratio index (APRI), and aspartate aminotransferase to alanine aminotransferase ratio (AAR) ( Giannini et al, 2003 ; Giannini et al, 2006 ; Hong et al, 2009 ; Kim et al, 2010 ; Colecchia et al, 2012 ; Berzigotti et al, 2013 ; Montasser et al, 2014 ; Morishita et al, 2014 ; Rockey et al, 2016 ). A few studies have reported the non-invasive prediction of EVB ( Kothari et al, 2019 ; Wan et al, 2021 ) and large EVs ( Sharma and Aggarwal, 2007 ; Lijing et al, 2014 ).…”